Recently, a photodynamic therapeutic approach targeting galectin-1 in bladder cancer cells and xenografts has inhibited tumour growth and enabled selective cytotoxicity in cancer cells, preventing undesired phototoxicity in the surrounding healthy tissues [99]. The gene discussed is LGALS1; the disease is urinary bladder carcinoma.